Veradermics’ Oral Hair-Loss Drug Shown to Boost Hair Growth in Late-Stage Study - Regional Media News

Veradermics' oral hair-loss drug shown to boost hair growth in late ...

Veradermics' VDPHL01 Meets All Endpoints in Phase 3 Study '304' Part A

The six-month, placebo-controlled portion of the trial enrolled 536 men with mild-to-moderate pattern hair loss.

Veradermics' oral hair-loss drug shown to boost hair growth in late-stage study

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.

Veradermics' oral Rogaine wins again at growing hair in late-stage trial

Veradermics is taking another victory lap with its oral twist on minoxidil, commonly known as Rogaine. The Connecticut biotech said VDPHL01, its extended-release version of the decades-old hair-regrowth drug, cleared all primary and secondary endpoints ...

Veradermics to Hold Conference Call to Discuss Topline Results from Phase 3 ‘304’ Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss